These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9631922)

  • 1. Therapeutic drug monitoring of vancomycin in a morbidly obese patient.
    Penzak SR; Gubbins PO; Rodvold KA; Hickerson SL
    Ther Drug Monit; 1998 Jun; 20(3):261-5. PubMed ID: 9631922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram.
    Yoon S; Park KR; Lee S; Song SH; Park WB; Jang IJ; Yu KS
    Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):233-238. PubMed ID: 28834212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosing vancomycin in the super obese: less is more.
    Crass RL; Dunn R; Hong J; Krop LC; Pai MP
    J Antimicrob Chemother; 2018 Nov; 73(11):3081-3086. PubMed ID: 30203073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin dosing in morbidly obese patients.
    Bauer LA; Black DJ; Lill JS
    Eur J Clin Pharmacol; 1998 Oct; 54(8):621-5. PubMed ID: 9860149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons.
    Elyasi S; Khalili H
    Eur J Clin Pharmacol; 2016 Jul; 72(7):777-88. PubMed ID: 27117446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized adjustment of vancomycin dosage: comparison with two dosage nomograms.
    Rybak MJ; Boike SC
    Drug Intell Clin Pharm; 1986 Jan; 20(1):64-8. PubMed ID: 3943460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring.
    Swartling M; Gupta R; Dudas V; Guglielmo BJ
    Int J Clin Pharm; 2012 Apr; 34(2):282-5. PubMed ID: 22331444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram based on actual body weight for estimation of vancomycin maintenance dose in infants.
    Pokorná P; Šíma M; Černá O; Slanař O
    Infect Dis (Lond); 2019 May; 51(5):334-339. PubMed ID: 30950674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a vancomycin dosing nomogram in achieving high target trough concentrations in Taiwanese patients.
    Leu WJ; Liu YC; Wang HW; Chien HY; Liu HP; Lin YM
    Int J Infect Dis; 2012 Nov; 16(11):e804-10. PubMed ID: 22917921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actual body weight-based vancomycin dosing in neonates.
    Pokorná P; Šíma M; Černá O; Allegaert K; Tibboel D; Slanař O
    J Chemother; 2019 Oct; 31(6):307-312. PubMed ID: 30983533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a vancomycin dosing nomogram to achieve the target area under the concentration-time curve. A retrospective study.
    Oda K; Katanoda T; Hashiguchi Y; Kondo S; Narita Y; Iwamura K; Nosaka K; Jono H; Saito H
    J Infect Chemother; 2020 May; 26(5):444-450. PubMed ID: 31879186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of elevated trough serum vancomycin concentrations with obesity.
    Richardson J; Scheetz M; O'Donnell EP
    J Infect Chemother; 2015 Jul; 21(7):507-11. PubMed ID: 25851852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin trough concentrations in overweight or obese pediatric patients.
    Heble DE; McPherson C; Nelson MP; Hunstad DA
    Pharmacotherapy; 2013 Dec; 33(12):1273-7. PubMed ID: 23798327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous intravenous vancomycin in children with normal renal function hospitalized in hematology-oncology: prospective validation of a dosing regimen optimizing steady-state concentration.
    Hoegy D; Goutelle S; Garnier N; Rénard C; Faure-Conter C; Bergeron C; Bertrand Y; Bleyzac N
    Fundam Clin Pharmacol; 2018 Jun; 32(3):323-329. PubMed ID: 29315849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
    Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
    Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic comparison of nomogram-based and individualized vancomycin regimens in neonates.
    Crumby T; Rinehart E; Carby MC; Kuhl D; Talati AJ
    Am J Health Syst Pharm; 2009 Jan; 66(2):149-53. PubMed ID: 19139479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levofloxacin dosing regimen in severely morbidly obese patients (BMI ≥40 kg/m(2)) should be guided by creatinine clearance estimates based on ideal body weight and optimized by therapeutic drug monitoring.
    Pai MP; Cojutti P; Pea F
    Clin Pharmacokinet; 2014 Aug; 53(8):753-62. PubMed ID: 24989061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes associated with AUC24/MIC nomogram dosing of vancomycin.
    Michalets EL; Pounders CL; Hollis SJ; Sutherland S
    Ann Pharmacother; 2011 May; 45(5):687-9. PubMed ID: 21521857
    [No Abstract]   [Full Text] [Related]  

  • 19. Vancomycin Dosing Considerations in a Real-World Cohort of Obese and Extremely Obese Patients.
    Morrill HJ; Caffrey AR; Noh E; LaPlante KL
    Pharmacotherapy; 2015 Sep; 35(9):869-75. PubMed ID: 26343549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment: outcomes associated with AUC₂₄/MIC nomogram dosing of vancomycin.
    Croes S; Neef C; Stolk LM
    Ann Pharmacother; 2011 Oct; 45(10):1313-4; author reply 1314-5. PubMed ID: 21934033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.